Literature DB >> 9099865

Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2.

H Ichinose1, J M Garnier, P Chambon, R Losson.   

Abstract

The human SNF2alpha (or hbrm) and SNF2beta (or BRG1) proteins have previously been shown to enhance transcriptional activation by nuclear receptors (NRs) in cultured human cells, and to be present in SWI/SNF complexes which are thought to be involved in control of transcription by facilitating remodelling of chromatin templates. Using the yeast two-hybrid system, we now demonstrate that the N-terminal regions of hSNF2alpha and hSNF2beta, preceding the DNA-dependent ATPase domain, specifically interact with the region of the estrogen receptor (ER) which includes the ligand binding domain and the ligand-dependent activation function AF-2. These interactions are increased by estrogen, but not by the ER AF-2 antagonist hydroxytamoxifen. Furthermore, mutants of ER that lack AF-2 activity are unable to interact with hSNF2alpha and -beta. These results suggest that the human homologues of the yeast SWI2/SNF2 protein may participate in the enhancement of transcription by the ER in vivo through interactions with the AF-2 activating domain, thus leading to ligand-dependent remodelling of chromatin templates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099865     DOI: 10.1016/s0378-1119(96)00785-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  41 in total

1.  Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor tau1 activation domain.

Authors:  A E Wallberg; K E Neely; A H Hassan; J A Gustafsson; J L Workman; A P Wright
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription.

Authors:  Zhi-Qing Huang; Jiwen Li; Laurent M Sachs; Philip A Cole; Jiemin Wong
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

3.  A methylation-mediator complex in hormone signaling.

Authors:  Wei Xu; Helen Cho; Shilpa Kadam; Ester M Banayo; Scott Anderson; John R Yates; Beverly M Emerson; Ronald M Evans
Journal:  Genes Dev       Date:  2004-01-16       Impact factor: 11.361

4.  Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, MAD2.

Authors:  G Poelzl; Y Kasai; N Mochizuki; P W Shaul; M Brown; M E Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 5.  Chromatin dynamics and the evolution of alternate promoter states.

Authors:  Gordon L Hager; Cem Elbi; Thomas A Johnson; Ty Voss; Akhilesh K Nagaich; R Louis Schiltz; Yi Qiu; Sam John
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

Review 6.  Nuclear receptors and chromatin remodeling machinery.

Authors:  Kevin W Trotter; Trevor K Archer
Journal:  Mol Cell Endocrinol       Date:  2007-01-19       Impact factor: 4.102

7.  SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells.

Authors:  C Sumi-Ichinose; H Ichinose; D Metzger; P Chambon
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

8.  Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro.

Authors:  Geetha V Rayasam; Cem Elbi; Dawn A Walker; Ronald Wolford; Terace M Fletcher; Dean P Edwards; Gordon L Hager
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.

Authors:  Kevin A Link; Craig J Burd; Erin Williams; Thomas Marshall; Gary Rosson; Erin Henry; Bernard Weissman; Karen E Knudsen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Histone H2A.Z is essential for estrogen receptor signaling.

Authors:  Nicolas Gévry; Sara Hardy; Pierre-Etienne Jacques; Liette Laflamme; Amy Svotelis; François Robert; Luc Gaudreau
Journal:  Genes Dev       Date:  2009-06-10       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.